Literature DB >> 2955036

Tolerance induction in mice by conjugates of monoclonal immunoglobulins and monomethoxypolyethylene glycol. Transfer of tolerance by T cells and by T cell extracts.

I Wilkinson, C J Jackson, G M Lang, V Holford-Strevens, A H Sehon.   

Abstract

The specific tolerance induced in mice by conjugates of human monoclonal IgG (HIgG) with monomethoxypolyethylene glycol (mPEG) was transferred to normal mice by spleen cells or a surface immunoglobulin negative (sIg-) Lyt-2+ subpopulation of these cells. Although transferable tolerance was demonstrable 6 to 14 days after treatment of the cell donors with tolerogen, the state of tolerance persisted in the treated mice for at least 43 days. Moreover, an extract prepared by freezing and thawing of the sIg- spleen cells obtained from mice 6 days after treatment with HIgG(mPEG)20 was capable of reducing (greater than 85%) the immune response of normal mice to heat aggregated HIgG. On the basis of these results, it is suggested that similar tolerogenic mPEG derivatives of xenogeneic monoclonal immunoglobulins (XIg) may prove to be useful therapeutic agents in man when administered before treatment with the unmodified XIg.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2955036

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Tolerogenic activity of polyethylene glycol-conjugated lysozyme distinct from that of the native counterpart.

Authors:  H O Ito; T So; M Hirata; T Koga; T Ueda; T Imoto
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

2.  Abrogation of antibody responses in rats to murine monoclonal antibody 791T/36 by treatment with daunomycin-cis-aconityl-791T/36 conjugates.

Authors:  L G Durrant; R A Robins; R A Marksman; M C Garnett; Y Ogunmuyiwa; R W Baldwin
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  Production of a human monoclonal antibody recognising a determinant on mouse IgG2b from a patient receiving mouse monoclonal antibody for diagnostic imaging.

Authors:  L G Durrant; R A Robins; K C Ballantyne; E B Austin; R W Baldwin
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

4.  PEGylated Adenoviruses: From Mice to Monkeys.

Authors:  Piyanuch Wonganan; Maria A Croyle
Journal:  Viruses       Date:  2010-02-01       Impact factor: 5.818

5.  Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase.

Authors:  Nancy J Ganson; Susan J Kelly; Edna Scarlett; John S Sundy; Michael S Hershfield
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

Review 6.  The First Bagshawe lecture. Towards generating cytotoxic agents at cancer sites.

Authors:  K D Bagshawe
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640

7.  Polyethylene glycol modification of a galactosylated streptavidin clearing agent: effects on immunogenicity and clearance of a biotinylated anti-tumour antibody.

Authors:  D Marshall; R B Pedley; J A Boden; R Boden; R G Melton; R H Begent
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.